S100A13 is a new angiogenic marker in human melanoma
Modern Pathology2010Vol. 23(6), pp. 804–813
Citations Over TimeTop 21% of 2010 papers
Daniela Massi, Matteo Landriscina, Annamaria Piscazzi, Elena Cosci, Alek Kirov, Milena Paglierani, Claudia Di Serio, Vasileios Mourmouras, Stefano Fumagalli, M. Biagioli, Igor Prudovsky, Clelia Miracco, Marco Santucci, Niccolò Marchionni, Francesca Tarantini
Related Papers
- → Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy(2008)351 cited
- → CD105 (Endoglin) as negative prognostic factor in AML(2019)27 cited
- Evaluation of Endoglin as an Angiogenesis Marker in Glioblastoma.(2015)
- Research progress in CD105 and its relation with tumors(2007)
- → Measurement of Microvessel Density Using CD105 (Endoglin) as a Marker in Prostatic Adenocarcinoma(2023)